ESPOSITO, Emanuela
 Distribuzione geografica
Continente #
NA - Nord America 13.096
AS - Asia 8.536
EU - Europa 8.472
SA - Sud America 3.191
AF - Africa 211
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 11
Totale 33.535
Nazione #
US - Stati Uniti d'America 12.747
SG - Singapore 3.865
BR - Brasile 2.825
CN - Cina 2.201
IE - Irlanda 2.192
SE - Svezia 1.808
IT - Italia 1.366
HK - Hong Kong 1.070
DE - Germania 639
VN - Vietnam 471
PL - Polonia 404
UA - Ucraina 402
GB - Regno Unito 366
FI - Finlandia 347
RU - Federazione Russa 333
IN - India 203
CA - Canada 186
FR - Francia 141
AR - Argentina 140
MX - Messico 121
AT - Austria 112
TR - Turchia 97
NL - Olanda 94
BE - Belgio 81
BD - Bangladesh 79
ID - Indonesia 76
ZA - Sudafrica 75
JP - Giappone 68
EC - Ecuador 64
IQ - Iraq 58
UZ - Uzbekistan 52
MA - Marocco 51
ES - Italia 48
PK - Pakistan 47
VE - Venezuela 43
IR - Iran 35
CO - Colombia 33
CZ - Repubblica Ceca 25
LT - Lituania 24
PY - Paraguay 23
AE - Emirati Arabi Uniti 22
CL - Cile 19
JO - Giordania 19
PE - Perù 19
IL - Israele 18
AZ - Azerbaigian 17
KG - Kirghizistan 16
TN - Tunisia 15
UY - Uruguay 15
DZ - Algeria 14
AU - Australia 13
KE - Kenya 13
NP - Nepal 13
EG - Egitto 12
SA - Arabia Saudita 12
TW - Taiwan 12
OM - Oman 11
KR - Corea 10
BO - Bolivia 9
CH - Svizzera 9
CI - Costa d'Avorio 9
HU - Ungheria 9
KZ - Kazakistan 9
DO - Repubblica Dominicana 8
NO - Norvegia 8
AL - Albania 7
EE - Estonia 7
GE - Georgia 7
PA - Panama 7
BY - Bielorussia 6
HN - Honduras 6
LB - Libano 6
PS - Palestinian Territory 6
RS - Serbia 6
AO - Angola 5
BG - Bulgaria 5
CR - Costa Rica 5
EU - Europa 5
GR - Grecia 5
JM - Giamaica 5
LA - Repubblica Popolare Democratica del Laos 5
SK - Slovacchia (Repubblica Slovacca) 5
XK - ???statistics.table.value.countryCode.XK??? 5
AM - Armenia 4
DK - Danimarca 4
LK - Sri Lanka 4
NZ - Nuova Zelanda 4
PT - Portogallo 4
RO - Romania 4
SV - El Salvador 4
TH - Thailandia 4
BA - Bosnia-Erzegovina 3
CG - Congo 3
DM - Dominica 3
MY - Malesia 3
PH - Filippine 3
SN - Senegal 3
BN - Brunei Darussalam 2
LV - Lettonia 2
ML - Mali 2
Totale 33.502
Città #
Dublin 2.192
Ashburn 1.741
Dallas 1.632
Chandler 1.614
Singapore 1.529
Nyköping 1.215
Hong Kong 1.061
Beijing 846
Jacksonville 825
Messina 414
Princeton 404
Warsaw 386
Los Angeles 352
Dearborn 348
Medford 312
The Dalles 282
New York 264
Boardman 259
Des Moines 258
Cambridge 250
Munich 235
Ann Arbor 232
São Paulo 224
Buffalo 178
Ho Chi Minh City 151
Lancaster 128
Redondo Beach 121
Tianjin 109
Rio de Janeiro 101
Shenyang 101
Jinan 100
Hanoi 92
Houston 89
Wilmington 88
Brussels 79
Moscow 78
Vienna 78
Nanjing 71
Rome 70
Belo Horizonte 67
Catania 65
San Mateo 64
Tokyo 62
Woodbridge 61
Pune 60
Montreal 59
Milan 58
Ottawa 57
Turku 53
Brooklyn 52
Cologne 52
Santa Clara 50
Dong Ket 48
Guangzhou 48
Hebei 48
Zhengzhou 47
Frankfurt am Main 46
Ningbo 46
Hyderabad 45
Chennai 44
Tashkent 44
Curitiba 43
London 43
Haikou 42
Jakarta 42
Mexico City 41
Denver 40
Johannesburg 40
San Francisco 40
Chicago 39
Düsseldorf 39
Brasília 38
Palermo 36
Seattle 36
Stockholm 36
Campinas 35
Poplar 34
Porto Alegre 34
Helsinki 33
Nanchang 33
Boston 32
Atlanta 30
Falls Church 30
Nuremberg 30
Orem 30
Taizhou 30
Guayaquil 29
Hangzhou 29
Salvador 29
Ankara 28
Baghdad 28
Lappeenranta 28
Francofonte 27
Phoenix 27
Washington 27
Amsterdam 26
Guarulhos 25
Buenos Aires 24
Fuzhou 24
Toronto 24
Totale 20.966
Nome #
Glycogen synthase kinase-3 beta inhibition reduces secondary damage in experimental spinal cord trauma. 228
Role of peroxisome proliferator-activated receptor-alpha in acute pancreatitis induced by cerulein 217
PPAR-α Modulates the Anti-Inflammatory Effect of Melatonin in the Secondary Events of Spinal Cord Injury 209
2-Pentadecyl-2-oxazoline, the oxazoline of PEA, modulates carrageenan-induced acute inflammation 183
Adelmidrol, a palmitoylethanolamide analogue, as a new pharmacological treatment for the management of inflammatory bowel disease 177
Celenterati Cnidari come modello per lo studio di tossicità da metalli pesanti. 172
Erratum to: Palmitoylethanolamide and luteolin ameliorate development of arthritis caused by injection of collagen type II in mice. 172
Influence of coagulase-negative staphylococci as potential probiotics on Dry Eye 163
Erratum to: Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain 162
The anti-inflammatory effects of palmitoylethanolamide (PEA) on endotoxin-induced uveitis in rats 162
3,5-Dicaffeoyl-4-malonylquinic acid reduced oxidative stress and inflammation in a experimental model of inflammatory bowel disease 159
Palmitoylethanolamide stimulation induces allopregnanolone synthesis in C6 cells and primary astrocytes: involvement of peroxisome-proliferator activated receptor-alpha 156
Absence of endogenous interleukin-10 enhanced organ dysfunction and mortality associated to zymosan-induced multiple organ dysfunction syndrome 148
B-Cell Depletion with CD20 Antibodies as New Approach in the Treatment of Inflammatory and Immunological Events Associated with Spinal Cord Injury 146
Absence of endogenous Interleukin-10 enhances secondary inflammatory process after spinal cord compression injury in mice. 146
Correction to: Potential eye drop based on a calix[4]arene nanoassembly for curcumin delivery: Enhanced drug solubility, stability, and anti-inflammatory effect (Molecular Pharmaceutics (2017) 14:5 (1610-1622) DOI: 10.1021/acs.molpharmaceut.6b01066) 144
Effect of cyclopentanone prostaglandin 15-deoxy-delta12,14PGJ2 on early functional recovery from experimental spinal cord injury 141
Dimethyl fumarate reduces inflammatory responses in experimental colitis 141
Adelmidrol, a palmitoylethanolamide analogue, as a new pharmacological treatment for the management of acute and chronic inflammation 140
Anti-inflammatory and Antioxidant Effects of Flavonoid-Rich Fraction of Bergamot Juice (BJe) in a Mouse Model of Intestinal Ischemia/Reperfusion Injury 139
B Cell depletion with CD20 antibodies as new approach in the treatment of inflammatory and immunological events associated with spinal cord 139
Ethyl-piruvate reduces the developments of zymosine-induced generalized inflammatory in mice 134
A Systematic Review and Meta-Analysis of the Association between the FV H1299R Variant and the Risk of Recurrent Pregnancy Loss 131
Role of melatonin supplementation in neurodegenerative disorders. 131
Beneficial effect of tempol, a membrane-permeable radical scavenger, on inflammation and osteoarthritis in in vitro models 131
Melatonin regulates matrix metalloproteinases after traumatic experimental spinal cord injury. 129
A role for nitric oxide-mediated peroxynitrite formation in a model of endotoxin-induced shock 127
Effects of Physical Exercise and Motor Activity on Oxidative Stress and Inflammation in Post Mastectomy Pain Syndrome 125
Beneficial Effects of Co-Ultramicronized Palmitoylethanolamide/Luteolin in a Mouse Model of Autism and in a Case Report of Autism 125
Co-Ultra PEALut Enhances Endogenous Repair Response Following Moderate Traumatic Brain Injury 125
The Neuroprotective Effect of Dimethyl Fumarate in an MPTP-Mouse Model of Parkinson's Disease: Involvement of Reactive Oxygen Species/Nuclear Factor-κB/Nuclear Transcription Factor Related to NF-E2 124
A new co-micronized composite containing palmitoylethanolamide and polydatin shows superior oral efficacy compared to their association in a rat paw model of carrageenan-induced inflammation 122
Administration of palmitoylethanolamide (PEA) protects the neurovascular unit and reduces secondary injury after traumatic brain injury in mice. 122
A novel protective formulation of Palmitoylethanolamide in experimental model of contrast agent induced nephropathy 120
Dimethyl fumarate attenuates neuroinflammation and neurobehavioral deficits induced by experimental traumatic brain injury 120
The neuroprotective effects of co-ultraPEALut in a mouse model of spinal cord injury 120
Glycogen synthase kinase 3 beta inhibition reduces the development of nonseptic shock induced by zymosan in mice 119
Adenosine A2A receptor selective stimulation reduces mitogen activated protein kinases in spinal cord injury: activation of jnk is reduced in oligodendrocytes 119
Co-ultramicronized palmitoylethanolamide/luteolin promotes neuronal regeneration after spinal cord injury 118
Dimethyl fumarate alleviates the nitroglycerin (NTG)-induced migraine in mice 118
TAK1 inhibitor enhances the therapeutic treatment for glioblastoma 117
Evaluation of a Product Containing Xyloglucan and Pea Protein on Skin Barrier Permeability 117
BAY-117082-driven NLRP3 inflammasome inhibition resolves nitro-glycerine (NTG) neuronal damage in in vivo model of migraine 116
Beneficial effect of KYP-2047, a propyl-oligopeptidase inhibitor, on oral squamous cell carcinoma 116
Recent Emerging Immunological Treatments for Primary Brain Tumors: Focus on Chemokine-Targeting Immunotherapies 114
Absence of peroxisome proliferators activated receptors alpha (PPAR-) enhanced the multiple organ failure induced by zymosan. 114
Aspetti tossicologici di estratto crudo da Pelagia noctiluca (Cnidaria: Scyphozoa). 114
B Cell-Targeted Therapy with Anti-CD20 Monoclonal Antibody Reduced Secondary Tissue Damage and Enhanced Behavioural Recovery Following Experimental Spinal Cord Injury in Mice 114
Protein Hydrolysates from Anchovy (Engraulis encrasicolus) Waste: In Vitro and In Vivo Biological Activities 114
N-palmitoylethanolamine administration ameliorates the clinical manifestation and progression of experimental autoimmune encephalomyelitis in rodents 113
Activation of sphingosine-1-phosphate receptor subtype 1 in the central nervous system contributes to morphine-induced hyperalgesia and antinociceptive tolerance in rodents 113
Effects of palmitoylethanolamide and silymarin combination treatment in an animal model of kidney ischemia and reperfusion 112
Effect of a Product Containing Xyloglucan and Pea Protein on a Murine Model of Atopic Dermatitis 112
H1299R Variant in Factor V and Recurrent Pregnancy Loss: A Systematic Review and Meta-Analysis Protocol 111
Adelmidrol, a palmitoylethanolamide analogue, as a new pharmacological treatment for the management of inflammatory bowel disease 111
Effect of ultra-micronized-palmitoylethanolamide and acetyl-l-carnitine on experimental model of inflammatory pain 111
A hydrogen sulfide-releasing cyclooxygenase inhibitor markedly accelerates recovery from experimental spinal cord injury. 110
Carbon dots as promising tools for cancer diagnosis and therapy 110
Efficacy of Xyloglucan against Escherichia coli Extraintestinal Urinary Tract Infection: An in vivo Study 109
The Association of Palmitoylethanolamide with Luteolin Decreases Autophagy in Spinal Cord Injury 109
Glucocorticoid-induced tumor necrosis factor receptor-related (GITR)-Fc fusion protein inhibits GITR triggering and protects from the inflammatory response after spinal cord injury 107
Antioxidant and anti-inflammatory effect of nrf2 inducer dimethyl fumarate in neurodegenerative diseases 107
Matrix metalloproteinase-9 and metalloproteinase-2 activity and expression is reduced by melatonin during experimental colitis. 106
The anti-inflammatory and antioxidant potential of pistachios (Pistacia vera L.) in vitro and in vivo 106
Role of natural antioxidants and potential use of bergamot in treating rheumatoid arthritis 104
Adenosine A2a receptor agonists reduce the apoptosis in an experimental model of spinal cord trauma (Biological Regulators and Homeostatical Agents (73)) 104
Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain 103
A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury 102
Fumaric Acid Esters Attenuate Secondary Degeneration and Promote Functional Recovery Following Experimental Spinal Cord Injury 102
A3 adenosine receptor agonist prevents the development of paclitaxel-induced neuropathic pain by modulating spinal glial-restricted redox-dependent signaling pathways. 101
Anti-inflammatory and neuroprotective effects of co-ultraPEALut in a mouse model of vascular dementia 101
TLR-4/Wnt modulation as new therapeutic strategy in the treatment of glioblastomas 101
PPAR-alpha Contributes to the Anti-Inflammatory Activity of Verbascoside in a Model of Inflammatory Bowel Disease in Mice 100
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-alpha MODULATES THE ANTI-INFLAMMATORY EFFECT OF GLUCOCORTICOIDS IN A MODEL OF INFLAMMATORY BOWEL DISEASE IN MICE. 100
Pharmacological Aspects and Biological Effects of Cannabigerol and Its Synthetic Derivatives 99
Absence of TLR4 reduces neurovascular unit and secondary inflammatory process after traumatic brain injury in mice 99
Co-ultramicronized Palmitoylethanolamide/Luteolin in the Treatment of Cerebral Ischemia: from Rodent to Man 99
Neuroprotective Effects of Temsirolimus in Animal Models of Parkinson's Disease 99
Efficacy of a Product Containing Xyloglucan and Pea Protein on Intestinal Barrier Function in a Partial Restraint Stress Animal Model 99
A Combination of Xyloglucan, Pea Protein and Chia Seed Ameliorates Intestinal Barrier Integrity and Mucosa Functionality in a Rat Model of Constipation-Predominant Irritable Bowel Syndrome 98
Anti-inflammatory effect of simvastatin in an experimental model of spinal cord trauma: involvement of PPAR-α. 98
Ultramicronized palmitoylethanolamide (PEA-um(®)) in the treatment of idiopathic pulmonary fibrosis 98
Liver X receptors activation, through TO901317 binding, reduces neuroinflammation in Parkinson's disease 98
Multiple mechanisms of dimethyl fumarate in amyloid β-induced neurotoxicity in human neuronal cells 98
The protective role of prolyl oligopeptidase (pop) inhibition in acute lung injury induced by intestinal ischemia-reperfusion 98
Neuroprotective effects of olprinone after cerebral ischemia/reperfusion injury in rats. 97
A New Approach for the Treatment of Recurrent Vulvovaginal Candidiasis with a Combination of Pea Protein, Grape Seed Extract, and Lactic Acid Assessed In Vivo 96
Autophagy and Liver Diseases 96
GW0742, a high-affinity PPAR -beta/delta agonist, inhibits acute lung injury in mice 95
Effects of a co-micronized composite containing palmitoylethanolamide and polydatin in an experimental model of benign prostatic hyperplasia 95
P12.05 Role of Dkk-3 in the neoplastic progression of meningiomas. Could it represent a new therapeutic target? 95
BENEFICIAL EFFECTS OF ETHYL PYRUVATE IN A MOUSE MODEL OF SPINAL CORD INJURY. 94
KU0063794, a Dual mTORC1 and mTORC2 Inhibitor, Reduces Neural Tissue Damage and Locomotor Impairment After Spinal Cord Injury in Mice 94
Protective effects of xyloglucan in association with the polysaccharide gelose in an experimental model of gastroenteritis and urinary tract infections 94
The anti-inflammatory and antioxidant effects of sodium propionate 94
Acute intracerebroventricular administration of palmitoylethanolamide, an endogenous peroxisome proliferator-activated receptor-alpha agonist, modulates carrageenan-induced paw edema in mice 93
Green Tea polyphenol extract attenuates zymosan-induced non-septic shock in mice 93
Fumaric acid esters attenuate degeneration and promote functional recovery following Parkinson’s disease 93
Therapeutic potential of flavonoids in the treatment of chronic venous insufficiency 93
Au, Pd and maghemite nanofunctionalized hydroxyapatite scaffolds for bone regeneration 93
Totale 12.003
Categoria #
all - tutte 143.890
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 143.890


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.227 0 0 0 0 0 148 87 224 324 227 93 124
2021/20222.328 23 173 55 92 117 36 181 91 75 132 470 883
2022/20236.430 533 524 288 528 465 644 95 356 2.705 46 178 68
2023/20241.837 128 271 108 156 157 404 82 101 23 99 35 273
2024/20258.678 164 89 259 405 410 248 278 1.590 2.144 505 1.047 1.539
2025/20269.346 1.344 1.595 2.023 1.965 2.132 287 0 0 0 0 0 0
Totale 34.393